Management of complications of Mycobacterium ulcerans disease: A three-year review

International Journal of Mycobacteriology - Tập 2 - Trang 206-210 - 2013
Emmanuel J.K. Adu1
1Department of Surgery, School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana

Tài liệu tham khảo

George, 1999, Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence, Science, 283, 854, 10.1126/science.283.5403.854 Stinear, 2004, Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans, Proc. Nat. Acad. Sci. USA, 101, 1345, 10.1073/pnas.0305877101 Pimsler, 1988, Immunosuppressive properties of the soluble toxin from Mycobacterium ulcerans, J. Infect. Dis., 157, 577, 10.1093/infdis/157.3.577 Buntine, 2001 C.R. Horsburgh, W.M. Meyers, Buruli ulcer, in: C.R. Horsburgh, A.M. Nelson (Eds.), Pathology of Emerging Infections, Am Soc Micro Washington D.C. 2005-4171, Ch 7, 1977, pp. 119–134. WHO, Provisional Guidelines on the Role of Specific Antibiotics in the Management of Mycobacterium ulcerans Disease (Buruli ulcer), World Health Organization, Geneva, Switzerland, 2004, WHO/CDS/CPE/GBUI/2004-10. Nienhuis, 2010, Antimicrobial treatment for early limited Mycobacterium ulcerans infection: a randomized control trial, Lancet, 375, 664, 10.1016/S0140-6736(09)61962-0 Adu, 2011, Surgical management of Buruli ulcer disease: a four year experience from four endemic districts in Ghana, Ghana Med. J., 45, 4, 10.4314/gmj.v45i1.68914 Amofah, 2002, Buruli ulcer in Ghana: results of a National case search, Emerg. Infect. Dis., 8, 167, 10.3201/eid0802.010119 Charity, 2009, Promising clinical efficacy of streptomycin–rifampicin combination for treatment of Buruli ulcer (Mycobacterium ulcerans) disease, Antimicrob. Agents Chemother., 5, 4029 Etuaful, 2005, Efficacy of the combination rifampicin–streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans, Antimicrob. Agents Chemother., 49, 3182, 10.1128/AAC.49.8.3182-3186.2005 WHO, Treatment of Mycobacterium ulcerans disease (Buruli ulcer): guidance for health workers, World Health Organization, Geneva, Switzerland, 2012, WHO/HTM/NTD/IDM/2012.1. Kassi, 2010, Squamous cell carcinoma secondary to Buruli ulcer: a clinical case report in a young girl, Bacteriol. Virusol. Parazitol. Epidemiol., 55, 25